ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections

• URL: http://arxiv.org/abs/2303.11434v1
• Date: Mon, 20 Mar 2023 20:27:11 GMT
• Title: ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections
• Authors: Partho Ghosh and Md. Aynal Haque
• Abstract summary: We present a deep learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The proposed model achieves the best Concordance Index (CI) performance in one of the largest benchmark datasets.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interactions, on the other hand, assume a continuous range of binding strength values, also known as binding affinity, and forecasting this value remains a difficulty. As the amount of affinity data in DT knowledge-bases grows, advanced learning techniques such as deep learning architectures can be used to predict binding affinities. In this paper, we present a deep-learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The results show that the proposed deep learning-based model that uses the 1D representations of targets and drugs is an effective approach for drug target binding affinity prediction and it does not require additional chemical domain knowledge to work with. The model in which high-level representations of a drug and a target are constructed via CNNs that uses residual skip connections and also with an additional stream to create a high-level combined representation of the drug-target pair achieved the best Concordance Index (CI) performance in one of the largest benchmark datasets, outperforming the recent state-of-the-art method AttentionDTA and many other machine-learning and deep-learning based baseline methods for DT binding affinity prediction that uses the 1D representations of targets and drugs.

Related papers

• FusionDTI: Fine-grained Binding Discovery with Token-level Fusion for Drug-Target Interaction [23.521628951362647]
  This paper introduces a novel model, called FusionDTI, which uses a token-level Fusion module to learn fine-grained information for Drug-Target Interaction. In particular, our FusionDTI model uses the SELFIES representation of drugs to mitigate sequence fragment invalidation. Our experiments show that our proposed FusionDTI model achieves the best performance in DTI prediction compared with seven existing state-of-the-art baselines.
  arXiv  Detail & Related papers  (2024-06-03T14:48:54Z)
• A Cross-Field Fusion Strategy for Drug-Target Interaction Prediction [85.2792480737546]
  Existing methods fail to utilize global protein information during DTI prediction. Cross-field information fusion strategy is employed to acquire local and global protein information. Siamese drug-target interaction SiamDTI prediction method achieves higher accuracy levels than other state-of-the-art (SOTA) methods on novel drugs and targets.
  arXiv  Detail & Related papers  (2024-05-23T13:25:20Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• PGraphDTA: Improving Drug Target Interaction Prediction using Protein Language Models and Contact Maps [4.590060921188914]
  Key aspect of drug discovery involves identifying novel drug-target (DT) interactions. Protein-ligand interactions exhibit a continuum of binding strengths, known as binding affinity. We propose novel enhancements to enhance their performance.
  arXiv  Detail & Related papers  (2023-10-06T05:00:25Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• Associative Learning Mechanism for Drug-Target Interaction Prediction [6.107658437700639]
  Drug-target affinity (DTA) represents the strength of drug-target interaction (DTI) Traditional methods lack the interpretability of the DTA prediction process. This paper proposes a DTA prediction method with interactive learning and an autoencoder mechanism.
  arXiv  Detail & Related papers  (2022-05-24T14:25:28Z)
• HampDTI: a heterogeneous graph automatic meta-path learning method for drug-target interaction prediction [4.499861098235355]
  We propose a heterogeneous graph automatic meta-path learning based DTI prediction method (HampDTI) HampDTI automatically learns the important meta-paths between drugs and targets from the HN, and generates meta-path graphs. Experiments on benchmark datasets show that our proposed HampDTI achieves superior performance compared with state-of-the-art DTI prediction methods.
  arXiv  Detail & Related papers  (2021-12-16T02:12:03Z)
• Toward Robust Drug-Target Interaction Prediction via Ensemble Modeling and Transfer Learning [0.0]
  We introduce an ensemble of deep learning models (EnsembleDLM) for robust DTI prediction. EnsembleDLM only uses the sequence information of chemical compounds and proteins, and it aggregates the predictions from multiple deep neural networks. It achieves state-of-the-art performance in Davis and KIBA datasets.
  arXiv  Detail & Related papers  (2021-07-02T04:00:03Z)
• MolTrans: Molecular Interaction Transformer for Drug Target Interaction Prediction [68.5766865583049]
  Drug target interaction (DTI) prediction is a foundational task for in silico drug discovery. Recent years have witnessed promising progress for deep learning in DTI predictions. We propose a Molecular Interaction Transformer (TransMol) to address these limitations.
  arXiv  Detail & Related papers  (2020-04-23T18:56:04Z)
• Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts [80.69440684790925]
  DeepRelations is a physics-inspired deep relational network with intrinsically explainable architecture. It shows superior interpretability to the state-of-the-art. It boosts the AUPRC of contact prediction 9.5, 16.9, 19.3 and 5.7-fold for the test, compound-unique, protein-unique, and both-unique sets.
  arXiv  Detail & Related papers  (2019-12-29T00:14:07Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.